126 related articles for article (PubMed ID: 10775108)
41. Regulatory vs. inflammatory cytokine T-cell responses to mutated insulin peptides in healthy and type 1 diabetic subjects.
Nakayama M; McDaniel K; Fitzgerald-Miller L; Kiekhaefer C; Snell-Bergeon JK; Davidson HW; Rewers M; Yu L; Gottlieb P; Kappler JW; Michels A
Proc Natl Acad Sci U S A; 2015 Apr; 112(14):4429-34. PubMed ID: 25831495
[TBL] [Abstract][Full Text] [Related]
42. Assessment of CD4+ T cell responses to glutamic acid decarboxylase 65 using DQ8 tetramers reveals a pathogenic role of GAD65 121-140 and GAD65 250-266 in T1D development.
Chow IT; Yang J; Gates TJ; James EA; Mai DT; Greenbaum C; Kwok WW
PLoS One; 2014; 9(11):e112882. PubMed ID: 25405480
[TBL] [Abstract][Full Text] [Related]
43. In vivo detection of peripherin-specific autoreactive B cells during type 1 diabetes pathogenesis.
Garabatos N; Alvarez R; Carrillo J; Carrascal J; Izquierdo C; Chapman HD; Presa M; Mora C; Serreze DV; Verdaguer J; Stratmann T
J Immunol; 2014 Apr; 192(7):3080-90. PubMed ID: 24610011
[TBL] [Abstract][Full Text] [Related]
44. Monoclonal antibody blocking the recognition of an insulin peptide-MHC complex modulates type 1 diabetes.
Zhang L; Crawford F; Yu L; Michels A; Nakayama M; Davidson HW; Kappler JW; Eisenbarth GS
Proc Natl Acad Sci U S A; 2014 Feb; 111(7):2656-61. PubMed ID: 24550292
[TBL] [Abstract][Full Text] [Related]
45. MHC Class II Protein Turnover In vivo and Its Relevance for Autoimmunity in Non-Obese Diabetic Mice.
De Riva A; Busch R
Front Immunol; 2013 Nov; 4():399. PubMed ID: 24324466
[TBL] [Abstract][Full Text] [Related]
46. MHC Class II Polymorphisms, Autoreactive T-Cells, and Autoimmunity.
Tsai S; Santamaria P
Front Immunol; 2013 Oct; 4():321. PubMed ID: 24133494
[TBL] [Abstract][Full Text] [Related]
47. Cholera toxin subunit B peptide fusion proteins reveal impaired oral tolerance induction in diabetes-prone but not in diabetes-resistant mice.
Presa M; Ortiz AZ; Garabatos N; Izquierdo C; Rivas EI; Teyton L; Mora C; Serreze D; Stratmann T
Eur J Immunol; 2013 Nov; 43(11):2969-79. PubMed ID: 23925934
[TBL] [Abstract][Full Text] [Related]
48. Distinct genetic control of autoimmune neuropathy and diabetes in the non-obese diabetic background.
Bour-Jordan H; Thompson HL; Giampaolo JR; Davini D; Rosenthal W; Bluestone JA
J Autoimmun; 2013 Sep; 45():58-67. PubMed ID: 23850635
[TBL] [Abstract][Full Text] [Related]
49. Differential binding of pyruvate dehydrogenase complex-E2 epitopes by DRB1*08:01 and DRB1*11:01 Is predicted by their structural motifs and correlates with disease risk.
Chow IT; James EA; Gates TJ; Tan V; Moustakas AK; Papadopoulos GK; Kwok WW
J Immunol; 2013 May; 190(9):4516-24. PubMed ID: 23543758
[TBL] [Abstract][Full Text] [Related]
50. Targeting the trimolecular complex.
Michels AW
Clin Immunol; 2013 Dec; 149(3):339-44. PubMed ID: 23537861
[TBL] [Abstract][Full Text] [Related]
51. The nonconventional MHC class II molecule DM governs diabetes susceptibility in NOD mice.
Morgan MA; Muller PS; Mould A; Newland SA; Nichols J; Robertson EJ; Cooke A; Bikoff EK
PLoS One; 2013; 8(2):e56738. PubMed ID: 23418596
[TBL] [Abstract][Full Text] [Related]
52. Immunotherapy in autoimmune type 1 diabetes.
Weigmann B; Franke RK; Daniel C
Rev Diabet Stud; 2012; 9(2-3):68-81. PubMed ID: 23403703
[TBL] [Abstract][Full Text] [Related]
53. Mechanistic basis of immunotherapies for type 1 diabetes mellitus.
Chen W; Xie A; Chan L
Transl Res; 2013 Apr; 161(4):217-29. PubMed ID: 23348026
[TBL] [Abstract][Full Text] [Related]
54. Therapeutic opportunities for manipulating T(Reg) cells in autoimmunity and cancer.
von Boehmer H; Daniel C
Nat Rev Drug Discov; 2013 Jan; 12(1):51-63. PubMed ID: 23274471
[TBL] [Abstract][Full Text] [Related]
55. Current and future immunomodulation strategies to restore tolerance in autoimmune diseases.
Bluestone JA; Bour-Jordan H
Cold Spring Harb Perspect Biol; 2012 Nov; 4(11):. PubMed ID: 23125012
[TBL] [Abstract][Full Text] [Related]
56. Autologous regulatory T cells for the treatment of type 1 diabetes.
Thompson JA; Perry D; Brusko TM
Curr Diab Rep; 2012 Oct; 12(5):623-32. PubMed ID: 22843491
[TBL] [Abstract][Full Text] [Related]
57. On the perils of poor editing: regulation of peptide loading by HLA-DQ and H2-A molecules associated with celiac disease and type 1 diabetes.
Busch R; De Riva A; Hadjinicolaou AV; Jiang W; Hou T; Mellins ED
Expert Rev Mol Med; 2012 Jul; 14():e15. PubMed ID: 22805744
[TBL] [Abstract][Full Text] [Related]
58. Treg vaccination with a strong-agonistic insulin mimetope.
Weigmann B; Daniel C
Curr Diab Rep; 2012 Oct; 12(5):463-70. PubMed ID: 22763731
[TBL] [Abstract][Full Text] [Related]
59. Immune modulating peptides for the treatment and suppression of multiple sclerosis.
Badawi AH; Siahaan TJ
Clin Immunol; 2012 Aug; 144(2):127-38. PubMed ID: 22722227
[TBL] [Abstract][Full Text] [Related]
60. Insulin as a key autoantigen in the development of type 1 diabetes.
Nakayama M
Diabetes Metab Res Rev; 2011 Nov; 27(8):773-7. PubMed ID: 22069258
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
